Kirby Institute
- Country
- 🇦🇺Australia
- Ownership
- Private
- Established
- 1986-01-01
- Employees
- 101
- Market Cap
- -
- Website
- https://kirby.unsw.edu.au
Antiretroviral Therapy Intensification With Raltegravir or Addition of Hyper-immune Bovine Colostrum in HIV-1 Infected Patients With Suboptimal CD4+ T Cell Response
- Conditions
- HIV Infections
- Interventions
- Drug: Hyper-immune Bovine ColostrumOther: raltegravir placeboOther: Hyper-immune Bovine Colostrum placebo
- First Posted Date
- 2008-10-15
- Last Posted Date
- 2012-08-24
- Lead Sponsor
- Kirby Institute
- Target Recruit Count
- 75
- Registration Number
- NCT00772590
Hepatitis B Acceptability and Vaccination Incentive Trial
- Conditions
- Hepatitis B
- Interventions
- Other: Incentive condition
- First Posted Date
- 2008-08-29
- Last Posted Date
- 2011-06-16
- Lead Sponsor
- Kirby Institute
- Target Recruit Count
- 204
- Registration Number
- NCT00744289
- Locations
- 🇦🇺
The Kirby Institute, Sydney, New South Wales, Australia
The Effect of Raltegravir on HIV Decay During Primary and Chronic Infection
- Conditions
- HIV Infection
- Interventions
- First Posted Date
- 2008-03-24
- Last Posted Date
- 2017-08-31
- Lead Sponsor
- Kirby Institute
- Target Recruit Count
- 16
- Registration Number
- NCT00641641
- Locations
- 🇦🇺
St Vincent's Hospital, Darlinghurst, Sydney, New South Wales, Australia
🇦🇺407 Doctors, Sydney, New South Wales, Australia
🇦🇺Holdsworth House Medical Practice, Sydney, New South Wales, Australia
A Prospective Study to Examine the Effectiveness and Safety of Antivirals in Volunteers Who Receive Short-term Prophylaxis Against Pandemic Influenza
- Conditions
- Pandemic Influenza
- First Posted Date
- 2008-03-21
- Last Posted Date
- 2012-04-24
- Lead Sponsor
- Kirby Institute
- Registration Number
- NCT00640874
- Locations
- 🇦🇺
St Vincent's Hospital, Sydney, New South Wales, Australia
🇦🇺Prince of Wales Hospital, Sydney, New South Wales, Australia
🇦🇺Westmead Hospital, Sydney, New South Wales, Australia
A Prospective Study to Examine the Effectiveness and Safety of Neuraminidase Inhibitors in Index Cases With Presumed Pandemic Influenza
- Conditions
- Pandemic Influenza
- First Posted Date
- 2008-03-21
- Last Posted Date
- 2012-04-24
- Lead Sponsor
- Kirby Institute
- Registration Number
- NCT00640302
- Locations
- 🇦🇺
St Vincent's Hospital, Sydney, New South Wales, Australia
🇦🇺Prince of Wales Hospital, Sydney, New South Wales, Australia
🇦🇺Westmead Hospital, Sydney, New South Wales, Australia
A Prospective Study to Examine the Effectiveness and Safety of Neuraminidase Inhibitors in Volunteers Who Receive Long-term Prophylaxis Against Pandemic Influenza: PIPET B
- Conditions
- Pandemic Influenza
- First Posted Date
- 2008-03-21
- Last Posted Date
- 2012-04-24
- Lead Sponsor
- Kirby Institute
- Registration Number
- NCT00640211
- Locations
- 🇦🇺
St Vincent's Hospital, Sydney, New South Wales, Australia
🇦🇺Prince of Wales Hospital, Sydney, New South Wales, Australia
🇦🇺Westmead Hospital, Sydney, New South Wales, Australia
ALTAIR - Alternative Antiretroviral Strategies : a Comparison of Three Initial Regimens
- Conditions
- Human Immunodeficiency Virus (HIV)
- Interventions
- First Posted Date
- 2006-06-09
- Last Posted Date
- 2019-09-26
- Lead Sponsor
- Kirby Institute
- Target Recruit Count
- 329
- Registration Number
- NCT00335322
Thai Prophylactic HIV Vaccine Phase I Study
- Conditions
- HIV
- Interventions
- Biological: pHIS-HIV-AE (DNA vaccine) prime and rFPV-HIV-AE (recombinant fowlpox virus boost) vaccine
- First Posted Date
- 2006-06-05
- Last Posted Date
- 2012-06-13
- Lead Sponsor
- Kirby Institute
- Target Recruit Count
- 8
- Registration Number
- NCT00333424
- Locations
- 🇹🇭
HIV-NAT (The HIV Netherlands Australia Thailand Research Collaboration), Thai Red Cross AIDS Research Centre, Bangkok, Thailand
ITV Extension Study
- Conditions
- HIV
- First Posted Date
- 2006-06-02
- Last Posted Date
- 2007-02-27
- Lead Sponsor
- Kirby Institute
- Target Recruit Count
- 35
- Registration Number
- NCT00332930
- Locations
- 🇦🇺
407 Doctors, Sydney, New South Wales, Australia
🇦🇺Ground Zero Medical Practice, Sydney, New South Wales, Australia
🇦🇺Holdsworth House Medical Practice, Sydney, New South Wales, Australia
Can Resistance Enhance Selection of Treatment? (CREST)
- Conditions
- HIV Infection
- First Posted Date
- 2005-12-07
- Last Posted Date
- 2025-06-26
- Lead Sponsor
- Kirby Institute
- Target Recruit Count
- 338
- Registration Number
- NCT00262717
- Locations
- 🇦🇺
Interchange General Practice, Canberra, Australian Capital Territory, Australia
🇦🇺Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia
🇦🇺Sydney Sexual Health Clinic, Sydney, New South Wales, Australia